Trump speaking to reporters at the White House in September. Photo: Bill O'Leary/The Washington Post via Getty Images

Pharmaceutical Research and Manufacturers of America (PhRMA) said in a statement Thursday that President Trump's executive order that appears to block federal contractors from holding anti-racist programs or diversity training is "ill-conceived and harmful" and asked that it be rescinded.

Why it matters: PhRMA president and CEO Stephen Ubl warned that the order puts "improper bureaucratic hurdles and restrictions on speech" within private companies that have contracts and grants with the federal government, jeopardizing "meaningful dialogue on the values for which this nation stands."

Context: Trump moved to halt federal agencies' anti-racism training in early September, then expanded the ban to federal contractors. The order suggests these sessions promote "radical ideologies that divide Americans by race or sex."

What they're saying: “The biopharmaceutical industry is doing everything it can to find vaccines and therapeutics to help end a pandemic that has had a disproportionate impact on Black and Brown communities," Ubl wrote in a statement Thursday.

  • “The issue of health inequities is not a new problem. It is a longstanding symptom of the systemic racism experienced by Black and Brown Americans throughout history. It is why our companies have committed to pushing for necessary, positive and long-term change to better address the needs of diverse communities."
  • "And it is why we must speak out against the president’s executive order restricting workplace diversity training programs and free speech within private companies that have contractual partnerships with or grants from the federal government."
  • “Diversity is essential to a robust innovation ecosystem that can create new medicines for those who need them."

The big picture: The Information Technology Industry Council, a tech industry lobbying group, also pushed back against the order last week.

  • CEO Jason Oxman wrote in a statement that it "attacks our broadly shared values and risks undoing real progress toward building racial equity in the tech industry and America writ large."

Go deeper

Amy Harder, author of Generate
Oct 23, 2020 - Energy & Environment

Climate change goes mainstream in presidential debate

Photo illustration: Aïda Amer/Axios. Photo: Olivier Douliery-Pool/Getty

The most notable part of Thursday’s presidential debate on climate change was the fact it was included as a topic and assumed as a fact.

The big picture: This is the first time in U.S. presidential history that climate change was a featured issue at a debate. It signals how the problem has become part of the fabric of our society. More extreme weather, like the wildfires ravaging Colorado, is pushing the topic to the front-burner.

Updated 15 mins ago - Politics & Policy

Coronavirus dashboard

Illustration: Sarah Grillo/Axios

  1. Politics: The swing states where the pandemic is raging — Pence no longer expected to attend Barrett confirmation vote after COVID exposure.
  2. Health: 13 states set single-day case records last week — U.S. reports over 80,000 new cases for second consecutive day.
  3. Business: Where stimulus is needed most.
  4. Education: The dangerous instability of school re-openings.
  5. World: Restrictions grow across Europe.
  6. Media: Fox News president and several hosts advised to quarantine.
Dave Lawler, author of World
41 mins ago - World

U.S.-brokered ceasefire collapses in Nagorno-Karabakh

Volunteer fighters in Stepanakert, the capital of Nagorno-Karabakh. Photo: Aris Messinis/AFP via Getty Images

A U.S.-brokered ceasefire between Armenia and Azerbaijan in the disputed territory of Nagorno-Karabakh crumbled within hours on Monday, leaving the month-old war rumbling on.

Why it matters: Nearly 5,000 people have been killed, according to Vladimir Putin’s rough estimate, including more than 100 civilians. Between 70,000 and 100,000 more are believed to have fled the fighting.

Get Axios AM in your inbox

Catch up on coronavirus stories and special reports, curated by Mike Allen everyday

Please enter a valid email.

Subscription failed
Thank you for subscribing!